BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 30013949)

  • 1. Diagnostic Value of Methylated
    Xie L; Jiang X; Li Q; Sun Z; Quan W; Duan Y; Li D; Chen T
    Front Oncol; 2018; 8():247. PubMed ID: 30013949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of circulating methylated Septin9 gene DNA in diagnosis and recurrence monitoring of colorectal cancer in Western China.
    Gao JJ; Wang YW; Li Y; Wang ZL; Feng A; Li N; Hui LY
    Clin Chim Acta; 2022 Dec; 537():118-126. PubMed ID: 36330944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylated Septin9 has moderate diagnostic value in colorectal cancer detection in Chinese population: a multicenter study.
    Lu DC; Zhang QF; Li L; Luo XK; Liang B; Lu YH; Hu BL; Jiang HX
    BMC Gastroenterol; 2022 May; 22(1):232. PubMed ID: 35546391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Value of Methylated Septin9 for Colorectal Cancer Screening: A Meta-Analysis.
    Yan S; Liu Z; Yu S; Bao Y
    Med Sci Monit; 2016 Sep; 22():3409-3418. PubMed ID: 27665580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylated Septin 9 as a Promising Biomarker in the Diagnosis and Recurrence Monitoring of Colorectal Cancer.
    Lu P; Zhu X; Song Y; Luo Y; Lin J; Zhang J; Cao Y; Huang Z
    Dis Markers; 2022; 2022():7087885. PubMed ID: 35818587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The stool
    Zhan Y; Wang S; Yuan Z; Zhao X; Ni K; Xin R; Zhou X; Liu Z; Yin X; Ping H; Liu Y; Wang W; Yan S; Han Q; Zhang X; Zhang Q; Liu Y; Zhang C
    Transl Cancer Res; 2023 Jan; 12(1):65-77. PubMed ID: 36760372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening and Prognostic Value of Methylated Septin9 and its Association With Clinicopathological and Molecular Characteristics in Colorectal Cancer.
    Sun J; Xu J; Sun C; Zheng M; Li Y; Zhu S; Zhang S
    Front Mol Biosci; 2021; 8():568818. PubMed ID: 34095214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Value and Clinical Significance of Methylated SEPT9 for Colorectal Cancer: A Meta-Analysis.
    Hu J; Hu B; Gui YC; Tan ZB; Xu JW
    Med Sci Monit; 2019 Aug; 25():5813-5822. PubMed ID: 31378778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Methylated SEPT9 as a Novel Biomarker for Predicting Liver Metastasis in Colorectal Cancer.
    Yu M; Yang C; Wang S; Shi Y; Wang J; Meng C; Xue L; Chen Z
    Mol Biotechnol; 2023 Aug; ():. PubMed ID: 37608077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylated Septin9 identified patients with colorectal carcinoma and showed higher sensitivity than conventional biomarkers in detecting tumor.
    Leerhoff S; Raem A; Kolbe EW; Schulz L; Borchers K; Köhler T; Winde G; Kirchner C
    Cancer Treat Res Commun; 2023; 36():100748. PubMed ID: 37541105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylated Septin9 (m
    Loomans-Kropp HA; Song Y; Gala M; Parikh AR; Van Seventer EE; Alvarez R; Hitchins MP; Shoemaker RH; Umar A
    Cancer Res Commun; 2022 Feb; 2(2):90-98. PubMed ID: 35992328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylated
    Hitchins MP; Vogelaar IP; Brennan K; Haraldsdottir S; Zhou N; Martin B; Alvarez R; Yuan X; Kim S; Guindi M; Hendifar AE; Kalady MF; DeVecchio J; Church JM; de la Chapelle A; Hampel H; Pearlman R; Christensen M; Snyder C; Lanspa SJ; Haile RW; Lynch HT
    BMJ Open Gastroenterol; 2019; 6(1):e000299. PubMed ID: 31275589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel microfluidic chip-based digital PCR method for enhanced sensitivity in the early diagnosis of colorectal cancer via mSEPT9.
    Huang Q; Xun Z; Lin J; Xie R; Zhu C; Wang L; Shang H; Wu S; Ou Q; Liu C
    Clin Chim Acta; 2024 Feb; 554():117781. PubMed ID: 38224929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opportunistic screening and survival prediction of digestive cancers by the combination of blood
    Song L; Chen Y; Gong Y; Wan J; Guo S; Liu H; Li Y; Zeng Z; Lu Y
    Ther Adv Med Oncol; 2020; 12():1758835920962966. PubMed ID: 33403008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review and meta-analysis: the diagnostic accuracy of methylated
    Chandrapalan S; Bannaga A; Weidner A; Hitchins MP; Arasaradnam RP
    Scand J Gastroenterol; 2022 Apr; 57(4):473-480. PubMed ID: 34957898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylated Septin 9 and Carcinoembryonic Antigen for Serological Diagnosis and Monitoring of Patients with Colorectal Cancer After Surgery.
    Ma ZY; Law WL; Ng EKO; Chan CSY; Lau KS; Cheng YY; Shin VY; Kwong A; Leung WK
    Sci Rep; 2019 Jul; 9(1):10326. PubMed ID: 31316143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of serum methylated septin 9 and carcinoembryonic antigen in efficacy evaluation and follow-up monitoring of colorectal cancer.
    Gao H; Zhu ZQ; Wusiman L; Wujieke A; Zhang WB
    Ann Ital Chir; 2023; 94():384-391. PubMed ID: 37794798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating methylated septin 9 nucleic Acid in the plasma of patients with gastrointestinal cancer in the stomach and colon.
    Lee HS; Hwang SM; Kim TS; Kim DW; Park DJ; Kang SB; Kim HH; Park KU
    Transl Oncol; 2013 Jun; 6(3):290-6. PubMed ID: 23730408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood leukocytes methylation levels analysis indicate methylated plasma test is a promising tool for colorectal cancer early detection.
    Chen Z; Zhao G; Wang K; Wang X; Ma Y; Xiong S; Zheng M; Fei S
    J Cancer; 2021; 12(12):3678-3685. PubMed ID: 33995643
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.